Recall archive / FDA drug enforcement
GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 516... — FDA record D-0870-2023
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Jun 6, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3
- Reason
- Labeling: Label Mix-up
- Classification
- Class III
- Recalling firm
- HF Acquisition Co LLC
- Quantity
- 9 boxes of 25 vials
- Agency-reported status
- Terminated
- Source record identifier
- D-0870-2023
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot #: 2205095.1, Exp. Date 7/31/2024 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Distributed in TX, AZ and CA only
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Jun 14, 2023
- Recall initiation date
- Jun 6, 2023
- Center classification date
- Jun 8, 2023
- Termination date
- Feb 27, 2024
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.